nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—bone marrow—lung cancer	0.017	0.0842	CbGeAlD
Amlexanox—S100A13—respiratory system—lung cancer	0.0138	0.0682	CbGeAlD
Amlexanox—S100A12—respiratory system—lung cancer	0.0136	0.0673	CbGeAlD
Amlexanox—FGF1—mammary gland—lung cancer	0.0127	0.063	CbGeAlD
Amlexanox—PDE4A—mammary gland—lung cancer	0.0121	0.0596	CbGeAlD
Amlexanox—S100A13—epithelium—lung cancer	0.0115	0.057	CbGeAlD
Amlexanox—S100A12—epithelium—lung cancer	0.0114	0.0562	CbGeAlD
Amlexanox—IL3—lymph node—lung cancer	0.0106	0.0522	CbGeAlD
Amlexanox—FGF1—respiratory system—lung cancer	0.00849	0.042	CbGeAlD
Amlexanox—S100A12—bone marrow—lung cancer	0.00797	0.0394	CbGeAlD
Amlexanox—Mouth ulceration—Gefitinib—lung cancer	0.00736	0.0412	CcSEcCtD
Amlexanox—S100A13—lung—lung cancer	0.00732	0.0362	CbGeAlD
Amlexanox—S100A12—lung—lung cancer	0.00722	0.0357	CbGeAlD
Amlexanox—FGF1—epithelium—lung cancer	0.0071	0.0351	CbGeAlD
Amlexanox—FGF1—cardiac atrium—lung cancer	0.00589	0.0292	CbGeAlD
Amlexanox—S100A13—lymph node—lung cancer	0.00501	0.0248	CbGeAlD
Amlexanox—S100A12—lymph node—lung cancer	0.00494	0.0244	CbGeAlD
Amlexanox—PDE4D—lung—lung cancer	0.00482	0.0238	CbGeAlD
Amlexanox—PDE4B—respiratory system—lung cancer	0.00479	0.0237	CbGeAlD
Amlexanox—FGF1—lung—lung cancer	0.00451	0.0223	CbGeAlD
Amlexanox—Stomatitis—Pemetrexed—lung cancer	0.00447	0.025	CcSEcCtD
Amlexanox—Liver function test abnormal—Teniposide—lung cancer	0.00445	0.0249	CcSEcCtD
Amlexanox—Stomatitis—Gefitinib—lung cancer	0.00444	0.0249	CcSEcCtD
Amlexanox—PDE4A—lung—lung cancer	0.00427	0.0211	CbGeAlD
Amlexanox—PDE4B—bronchus—lung cancer	0.00394	0.0195	CbGeAlD
Amlexanox—Throat sore—Paclitaxel—lung cancer	0.00393	0.022	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Paclitaxel—lung cancer	0.00389	0.0218	CcSEcCtD
Amlexanox—Stomatitis—Teniposide—lung cancer	0.00362	0.0203	CcSEcCtD
Amlexanox—PDE4B—trachea—lung cancer	0.00354	0.0175	CbGeAlD
Amlexanox—Throat sore—Docetaxel—lung cancer	0.00333	0.0186	CcSEcCtD
Amlexanox—PDE4B—cardiac atrium—lung cancer	0.00332	0.0164	CbGeAlD
Amlexanox—Oropharyngeal discomfort—Docetaxel—lung cancer	0.0033	0.0185	CcSEcCtD
Amlexanox—PDE4D—lymph node—lung cancer	0.0033	0.0163	CbGeAlD
Amlexanox—Aphthous stomatitis—Doxorubicin—lung cancer	0.00319	0.0179	CcSEcCtD
Amlexanox—Nervous system disorder—Crizotinib—lung cancer	0.00314	0.0176	CcSEcCtD
Amlexanox—Oropharyngeal pain—Paclitaxel—lung cancer	0.00311	0.0174	CcSEcCtD
Amlexanox—FGF1—lymph node—lung cancer	0.00308	0.0153	CbGeAlD
Amlexanox—PDE4A—lymph node—lung cancer	0.00292	0.0144	CbGeAlD
Amlexanox—Paraesthesia—Crizotinib—lung cancer	0.00287	0.0161	CcSEcCtD
Amlexanox—Nervous system disorder—Pemetrexed—lung cancer	0.00287	0.0161	CcSEcCtD
Amlexanox—Nervous system disorder—Gefitinib—lung cancer	0.00285	0.0159	CcSEcCtD
Amlexanox—PDE4B—bone marrow—lung cancer	0.00281	0.0139	CbGeAlD
Amlexanox—Gastrointestinal disorder—Crizotinib—lung cancer	0.00276	0.0155	CcSEcCtD
Amlexanox—Stomatitis—Topotecan—lung cancer	0.00268	0.015	CcSEcCtD
Amlexanox—Stomatitis—Erlotinib—lung cancer	0.00266	0.0149	CcSEcCtD
Amlexanox—Oropharyngeal pain—Docetaxel—lung cancer	0.00264	0.0148	CcSEcCtD
Amlexanox—Mouth ulceration—Etoposide—lung cancer	0.00261	0.0146	CcSEcCtD
Amlexanox—Mouth ulceration—Paclitaxel—lung cancer	0.00256	0.0143	CcSEcCtD
Amlexanox—PDE4B—lung—lung cancer	0.00254	0.0126	CbGeAlD
Amlexanox—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00253	0.0141	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Gefitinib—lung cancer	0.00251	0.014	CcSEcCtD
Amlexanox—Pain—Pemetrexed—lung cancer	0.0025	0.014	CcSEcCtD
Amlexanox—Pain—Gefitinib—lung cancer	0.00249	0.0139	CcSEcCtD
Amlexanox—Stomatitis—Vinorelbine—lung cancer	0.0023	0.0128	CcSEcCtD
Amlexanox—Liver function test abnormal—Gemcitabine—lung cancer	0.00227	0.0127	CcSEcCtD
Amlexanox—Nausea—Crizotinib—lung cancer	0.0019	0.0106	CcSEcCtD
Amlexanox—Liver function test abnormal—Paclitaxel—lung cancer	0.0019	0.0106	CcSEcCtD
Amlexanox—Stomatitis—Irinotecan—lung cancer	0.00189	0.0106	CcSEcCtD
Amlexanox—Stomatitis—Gemcitabine—lung cancer	0.00184	0.0103	CcSEcCtD
Amlexanox—PDE4B—lymph node—lung cancer	0.00174	0.0086	CbGeAlD
Amlexanox—Nausea—Pemetrexed—lung cancer	0.00174	0.00972	CcSEcCtD
Amlexanox—Nausea—Gefitinib—lung cancer	0.00173	0.00966	CcSEcCtD
Amlexanox—Nervous system disorder—Topotecan—lung cancer	0.00172	0.00964	CcSEcCtD
Amlexanox—Stomatitis—Cisplatin—lung cancer	0.00172	0.00962	CcSEcCtD
Amlexanox—Nervous system disorder—Erlotinib—lung cancer	0.0017	0.00953	CcSEcCtD
Amlexanox—Paraesthesia—Vinblastine—lung cancer	0.00162	0.00908	CcSEcCtD
Amlexanox—Liver function test abnormal—Docetaxel—lung cancer	0.00161	0.009	CcSEcCtD
Amlexanox—Paraesthesia—Topotecan—lung cancer	0.00158	0.00882	CcSEcCtD
Amlexanox—Stomatitis—Etoposide—lung cancer	0.00157	0.00881	CcSEcCtD
Amlexanox—Mouth ulceration—Methotrexate—lung cancer	0.00156	0.00875	CcSEcCtD
Amlexanox—Pain—Vinblastine—lung cancer	0.00155	0.00865	CcSEcCtD
Amlexanox—Stomatitis—Paclitaxel—lung cancer	0.00154	0.00864	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Topotecan—lung cancer	0.00152	0.00848	CcSEcCtD
Amlexanox—Pain—Topotecan—lung cancer	0.0015	0.0084	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Erlotinib—lung cancer	0.0015	0.00839	CcSEcCtD
Amlexanox—Pain—Erlotinib—lung cancer	0.00149	0.00831	CcSEcCtD
Amlexanox—Headache—Teniposide—lung cancer	0.00148	0.00831	CcSEcCtD
Amlexanox—Nervous system disorder—Vinorelbine—lung cancer	0.00147	0.00824	CcSEcCtD
Amlexanox—Nausea—Teniposide—lung cancer	0.00141	0.00788	CcSEcCtD
Amlexanox—Mouth ulceration—Doxorubicin—lung cancer	0.00135	0.00758	CcSEcCtD
Amlexanox—Paraesthesia—Vinorelbine—lung cancer	0.00135	0.00755	CcSEcCtD
Amlexanox—Stomatitis—Docetaxel—lung cancer	0.00131	0.00732	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Vinorelbine—lung cancer	0.0013	0.00726	CcSEcCtD
Amlexanox—Pain—Vinorelbine—lung cancer	0.00128	0.00719	CcSEcCtD
Amlexanox—Nervous system disorder—Irinotecan—lung cancer	0.00121	0.0068	CcSEcCtD
Amlexanox—Nervous system disorder—Gemcitabine—lung cancer	0.00118	0.00662	CcSEcCtD
Amlexanox—Liver function test abnormal—Methotrexate—lung cancer	0.00116	0.00649	CcSEcCtD
Amlexanox—Headache—Vinblastine—lung cancer	0.00113	0.00634	CcSEcCtD
Amlexanox—Paraesthesia—Irinotecan—lung cancer	0.00111	0.00623	CcSEcCtD
Amlexanox—Nervous system disorder—Cisplatin—lung cancer	0.0011	0.00617	CcSEcCtD
Amlexanox—Headache—Topotecan—lung cancer	0.0011	0.00616	CcSEcCtD
Amlexanox—Headache—Erlotinib—lung cancer	0.00109	0.00609	CcSEcCtD
Amlexanox—Paraesthesia—Gemcitabine—lung cancer	0.00108	0.00606	CcSEcCtD
Amlexanox—Nausea—Vinblastine—lung cancer	0.00107	0.00601	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Irinotecan—lung cancer	0.00107	0.00599	CcSEcCtD
Amlexanox—Pain—Irinotecan—lung cancer	0.00106	0.00593	CcSEcCtD
Amlexanox—Nausea—Topotecan—lung cancer	0.00104	0.00584	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00104	0.00583	CcSEcCtD
Amlexanox—Pain—Gemcitabine—lung cancer	0.00103	0.00578	CcSEcCtD
Amlexanox—Nausea—Erlotinib—lung cancer	0.00103	0.00578	CcSEcCtD
Amlexanox—Paraesthesia—Cisplatin—lung cancer	0.00101	0.00565	CcSEcCtD
Amlexanox—Liver function test abnormal—Doxorubicin—lung cancer	0.001	0.00562	CcSEcCtD
Amlexanox—Nervous system disorder—Paclitaxel—lung cancer	0.000991	0.00554	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Cisplatin—lung cancer	0.000971	0.00543	CcSEcCtD
Amlexanox—Pain—Cisplatin—lung cancer	0.000962	0.00538	CcSEcCtD
Amlexanox—Stomatitis—Methotrexate—lung cancer	0.000943	0.00528	CcSEcCtD
Amlexanox—Headache—Vinorelbine—lung cancer	0.000941	0.00527	CcSEcCtD
Amlexanox—Paraesthesia—Etoposide—lung cancer	0.000925	0.00518	CcSEcCtD
Amlexanox—Paraesthesia—Paclitaxel—lung cancer	0.000907	0.00508	CcSEcCtD
Amlexanox—Nausea—Vinorelbine—lung cancer	0.000892	0.00499	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Etoposide—lung cancer	0.00089	0.00498	CcSEcCtD
Amlexanox—Pain—Etoposide—lung cancer	0.000881	0.00493	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000872	0.00488	CcSEcCtD
Amlexanox—Pain—Paclitaxel—lung cancer	0.000864	0.00484	CcSEcCtD
Amlexanox—Nervous system disorder—Docetaxel—lung cancer	0.00084	0.0047	CcSEcCtD
Amlexanox—Stomatitis—Doxorubicin—lung cancer	0.000817	0.00457	CcSEcCtD
Amlexanox—Headache—Irinotecan—lung cancer	0.000776	0.00434	CcSEcCtD
Amlexanox—Paraesthesia—Docetaxel—lung cancer	0.000769	0.0043	CcSEcCtD
Amlexanox—Headache—Gemcitabine—lung cancer	0.000756	0.00423	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Docetaxel—lung cancer	0.000739	0.00414	CcSEcCtD
Amlexanox—Nausea—Irinotecan—lung cancer	0.000736	0.00412	CcSEcCtD
Amlexanox—Pain—Docetaxel—lung cancer	0.000732	0.0041	CcSEcCtD
Amlexanox—Nausea—Gemcitabine—lung cancer	0.000717	0.00401	CcSEcCtD
Amlexanox—Nausea—Cisplatin—lung cancer	0.000668	0.00374	CcSEcCtD
Amlexanox—Headache—Etoposide—lung cancer	0.000646	0.00361	CcSEcCtD
Amlexanox—Headache—Paclitaxel—lung cancer	0.000633	0.00354	CcSEcCtD
Amlexanox—Nausea—Etoposide—lung cancer	0.000612	0.00343	CcSEcCtD
Amlexanox—Nervous system disorder—Methotrexate—lung cancer	0.000605	0.00339	CcSEcCtD
Amlexanox—Nausea—Paclitaxel—lung cancer	0.0006	0.00336	CcSEcCtD
Amlexanox—Paraesthesia—Methotrexate—lung cancer	0.000554	0.0031	CcSEcCtD
Amlexanox—Headache—Docetaxel—lung cancer	0.000536	0.003	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Methotrexate—lung cancer	0.000533	0.00298	CcSEcCtD
Amlexanox—Pain—Methotrexate—lung cancer	0.000528	0.00295	CcSEcCtD
Amlexanox—Nervous system disorder—Doxorubicin—lung cancer	0.000524	0.00293	CcSEcCtD
Amlexanox—Nausea—Docetaxel—lung cancer	0.000509	0.00285	CcSEcCtD
Amlexanox—Paraesthesia—Doxorubicin—lung cancer	0.00048	0.00269	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000461	0.00258	CcSEcCtD
Amlexanox—Pain—Doxorubicin—lung cancer	0.000457	0.00256	CcSEcCtD
Amlexanox—Headache—Methotrexate—lung cancer	0.000387	0.00216	CcSEcCtD
Amlexanox—Nausea—Methotrexate—lung cancer	0.000367	0.00205	CcSEcCtD
Amlexanox—Headache—Doxorubicin—lung cancer	0.000335	0.00187	CcSEcCtD
Amlexanox—Nausea—Doxorubicin—lung cancer	0.000317	0.00178	CcSEcCtD
Amlexanox—PDE4A—Signaling Pathways—EGF—lung cancer	3.31e-05	5.35e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BRAF—lung cancer	3.31e-05	5.34e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HIF1A—lung cancer	3.28e-05	5.3e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6R—lung cancer	3.27e-05	5.28e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CREBBP—lung cancer	3.26e-05	5.27e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MDM2—lung cancer	3.25e-05	5.25e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—RAF1—lung cancer	3.24e-05	5.23e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—lung cancer	3.24e-05	5.23e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK3—lung cancer	3.21e-05	5.18e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KRAS—lung cancer	3.21e-05	5.18e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—lung cancer	3.21e-05	5.18e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB2—lung cancer	3.21e-05	5.18e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PIK3CA—lung cancer	3.2e-05	5.16e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—lung cancer	3.19e-05	5.15e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HRAS—lung cancer	3.19e-05	5.15e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MDM2—lung cancer	3.18e-05	5.14e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—lung cancer	3.18e-05	5.13e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RAF1—lung cancer	3.17e-05	5.13e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOA1—lung cancer	3.17e-05	5.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTOR—lung cancer	3.16e-05	5.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PIK3CB—lung cancer	3.16e-05	5.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—lung cancer	3.16e-05	5.1e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BRAF—lung cancer	3.15e-05	5.09e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—lung cancer	3.15e-05	5.08e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB2—lung cancer	3.14e-05	5.07e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KDR—lung cancer	3.14e-05	5.07e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—lung cancer	3.13e-05	5.06e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAP2K1—lung cancer	3.11e-05	5.03e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6R—lung cancer	3.11e-05	5.02e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CREBBP—lung cancer	3.11e-05	5.02e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APC—lung cancer	3.1e-05	5.01e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CG—lung cancer	3.1e-05	5.01e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KIT—lung cancer	3.1e-05	5.01e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—NRAS—lung cancer	3.1e-05	5.01e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MTOR—lung cancer	3.1e-05	5e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CB—lung cancer	3.1e-05	5e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CD—lung cancer	3.09e-05	5e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—PIK3CA—lung cancer	3.07e-05	4.95e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGF—lung cancer	3.06e-05	4.95e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—JUN—lung cancer	3.06e-05	4.94e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—lung cancer	3.05e-05	4.93e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—KRAS—lung cancer	3.03e-05	4.89e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—lung cancer	2.99e-05	4.82e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—lung cancer	2.98e-05	4.81e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK3—lung cancer	2.97e-05	4.8e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1A—lung cancer	2.97e-05	4.79e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAP2K1—lung cancer	2.96e-05	4.79e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PTEN—lung cancer	2.96e-05	4.78e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—HRAS—lung cancer	2.96e-05	4.78e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—lung cancer	2.95e-05	4.77e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PIK3CA—lung cancer	2.95e-05	4.76e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CD—lung cancer	2.95e-05	4.76e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—lung cancer	2.93e-05	4.73e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—PIK3CA—lung cancer	2.92e-05	4.71e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BRAF—lung cancer	2.91e-05	4.71e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KIT—lung cancer	2.89e-05	4.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APC—lung cancer	2.89e-05	4.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CG—lung cancer	2.89e-05	4.67e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—KRAS—lung cancer	2.88e-05	4.66e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6R—lung cancer	2.88e-05	4.65e-05	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—lung cancer	2.88e-05	4.65e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CREBBP—lung cancer	2.87e-05	4.64e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGF—lung cancer	2.86e-05	4.61e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—lung cancer	2.85e-05	4.61e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CASP3—lung cancer	2.85e-05	4.6e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—lung cancer	2.85e-05	4.6e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—lung cancer	2.83e-05	4.57e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—lung cancer	2.82e-05	4.56e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EP300—lung cancer	2.82e-05	4.56e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—lung cancer	2.81e-05	4.54e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PIK3CA—lung cancer	2.78e-05	4.5e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCND1—lung cancer	2.77e-05	4.48e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MDM2—lung cancer	2.77e-05	4.48e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JUN—lung cancer	2.77e-05	4.47e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RAF1—lung cancer	2.76e-05	4.46e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—lung cancer	2.75e-05	4.44e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—SRC—lung cancer	2.75e-05	4.43e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAP2K1—lung cancer	2.74e-05	4.43e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1A—lung cancer	2.74e-05	4.42e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTEN—lung cancer	2.73e-05	4.41e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB2—lung cancer	2.73e-05	4.41e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HRAS—lung cancer	2.73e-05	4.41e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CD—lung cancer	2.73e-05	4.4e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BRAF—lung cancer	2.72e-05	4.39e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PIK3CA—lung cancer	2.7e-05	4.36e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CB—lung cancer	2.7e-05	4.36e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MTOR—lung cancer	2.7e-05	4.36e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—lung cancer	2.69e-05	4.35e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6R—lung cancer	2.68e-05	4.34e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1A—lung cancer	2.68e-05	4.33e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CREBBP—lung cancer	2.68e-05	4.33e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTEN—lung cancer	2.68e-05	4.32e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—KRAS—lung cancer	2.67e-05	4.31e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PIK3CA—lung cancer	2.65e-05	4.28e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—STAT3—lung cancer	2.65e-05	4.28e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NRAS—lung cancer	2.64e-05	4.27e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MDM2—lung cancer	2.64e-05	4.26e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RAF1—lung cancer	2.63e-05	4.25e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—lung cancer	2.61e-05	4.22e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—lung cancer	2.61e-05	4.22e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—EP300—lung cancer	2.61e-05	4.21e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB2—lung cancer	2.6e-05	4.2e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—lung cancer	2.59e-05	4.19e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HRAS—lung cancer	2.58e-05	4.16e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MTOR—lung cancer	2.57e-05	4.15e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CB—lung cancer	2.57e-05	4.15e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAP2K1—lung cancer	2.56e-05	4.13e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EP300—lung cancer	2.55e-05	4.12e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CD—lung cancer	2.54e-05	4.1e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—SRC—lung cancer	2.53e-05	4.09e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK3—lung cancer	2.53e-05	4.09e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—lung cancer	2.5e-05	4.04e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SRC—lung cancer	2.48e-05	4.01e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CASP3—lung cancer	2.48e-05	4.01e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—lung cancer	2.48e-05	4e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—lung cancer	2.47e-05	3.98e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—lung cancer	2.46e-05	3.98e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PIK3CA—lung cancer	2.45e-05	3.96e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HRAS—lung cancer	2.45e-05	3.96e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—STAT3—lung cancer	2.44e-05	3.95e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MDM2—lung cancer	2.44e-05	3.94e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—NRAS—lung cancer	2.44e-05	3.94e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RAF1—lung cancer	2.43e-05	3.93e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—lung cancer	2.42e-05	3.91e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCND1—lung cancer	2.41e-05	3.9e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JUN—lung cancer	2.41e-05	3.89e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—lung cancer	2.41e-05	3.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB2—lung cancer	2.41e-05	3.89e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—lung cancer	2.41e-05	3.89e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—STAT3—lung cancer	2.39e-05	3.87e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NRAS—lung cancer	2.39e-05	3.86e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—lung cancer	2.38e-05	3.85e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MTOR—lung cancer	2.38e-05	3.84e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CB—lung cancer	2.38e-05	3.84e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CASP3—lung cancer	2.36e-05	3.81e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—lung cancer	2.36e-05	3.81e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—lung cancer	2.35e-05	3.79e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—lung cancer	2.34e-05	3.79e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1A—lung cancer	2.34e-05	3.77e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK3—lung cancer	2.34e-05	3.77e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTEN—lung cancer	2.33e-05	3.76e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCND1—lung cancer	2.3e-05	3.71e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JUN—lung cancer	2.29e-05	3.7e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK3—lung cancer	2.29e-05	3.69e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—lung cancer	2.28e-05	3.69e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MDM2—lung cancer	2.28e-05	3.68e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—lung cancer	2.27e-05	3.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KRAS—lung cancer	2.27e-05	3.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—lung cancer	2.27e-05	3.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RAF1—lung cancer	2.27e-05	3.66e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HRAS—lung cancer	2.27e-05	3.66e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB2—lung cancer	2.24e-05	3.63e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—lung cancer	2.23e-05	3.6e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—lung cancer	2.22e-05	3.59e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1A—lung cancer	2.22e-05	3.59e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EP300—lung cancer	2.22e-05	3.59e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—lung cancer	2.22e-05	3.59e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTEN—lung cancer	2.22e-05	3.58e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MTOR—lung cancer	2.21e-05	3.58e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CB—lung cancer	2.21e-05	3.58e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—lung cancer	2.21e-05	3.56e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CASP3—lung cancer	2.18e-05	3.53e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—lung cancer	2.18e-05	3.52e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—lung cancer	2.18e-05	3.51e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—lung cancer	2.17e-05	3.51e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—lung cancer	2.16e-05	3.5e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SRC—lung cancer	2.16e-05	3.49e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—lung cancer	2.13e-05	3.44e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCND1—lung cancer	2.13e-05	3.43e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JUN—lung cancer	2.12e-05	3.43e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EP300—lung cancer	2.12e-05	3.42e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—lung cancer	2.11e-05	3.4e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—KRAS—lung cancer	2.1e-05	3.39e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PIK3CA—lung cancer	2.09e-05	3.37e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT3—lung cancer	2.08e-05	3.37e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NRAS—lung cancer	2.08e-05	3.36e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—lung cancer	2.06e-05	3.33e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1A—lung cancer	2.06e-05	3.32e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SRC—lung cancer	2.06e-05	3.32e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KRAS—lung cancer	2.06e-05	3.32e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTEN—lung cancer	2.05e-05	3.32e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CASP3—lung cancer	2.04e-05	3.29e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—lung cancer	2.03e-05	3.29e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—lung cancer	2e-05	3.24e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—lung cancer	2e-05	3.23e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK3—lung cancer	1.99e-05	3.22e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT3—lung cancer	1.98e-05	3.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCND1—lung cancer	1.98e-05	3.2e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NRAS—lung cancer	1.98e-05	3.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JUN—lung cancer	1.98e-05	3.2e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EP300—lung cancer	1.96e-05	3.16e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—lung cancer	1.94e-05	3.13e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HRAS—lung cancer	1.93e-05	3.12e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PIK3CA—lung cancer	1.93e-05	3.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—lung cancer	1.93e-05	3.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1A—lung cancer	1.92e-05	3.1e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTEN—lung cancer	1.91e-05	3.09e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SRC—lung cancer	1.9e-05	3.07e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK3—lung cancer	1.9e-05	3.06e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—lung cancer	1.89e-05	3.06e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CA—lung cancer	1.89e-05	3.05e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—lung cancer	1.85e-05	2.99e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—lung cancer	1.85e-05	2.99e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—lung cancer	1.84e-05	2.98e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT3—lung cancer	1.84e-05	2.97e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NRAS—lung cancer	1.83e-05	2.96e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—lung cancer	1.83e-05	2.95e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EP300—lung cancer	1.83e-05	2.95e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—lung cancer	1.8e-05	2.91e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KRAS—lung cancer	1.79e-05	2.89e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—HRAS—lung cancer	1.78e-05	2.88e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SRC—lung cancer	1.77e-05	2.87e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK3—lung cancer	1.75e-05	2.83e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HRAS—lung cancer	1.75e-05	2.82e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—lung cancer	1.73e-05	2.79e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT3—lung cancer	1.71e-05	2.76e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NRAS—lung cancer	1.71e-05	2.76e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—lung cancer	1.71e-05	2.76e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—lung cancer	1.71e-05	2.76e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—lung cancer	1.71e-05	2.76e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KRAS—lung cancer	1.7e-05	2.75e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—lung cancer	1.67e-05	2.7e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—lung cancer	1.67e-05	2.69e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CA—lung cancer	1.64e-05	2.66e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK3—lung cancer	1.64e-05	2.64e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—lung cancer	1.59e-05	2.57e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—lung cancer	1.59e-05	2.57e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KRAS—lung cancer	1.58e-05	2.55e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—lung cancer	1.58e-05	2.54e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CA—lung cancer	1.57e-05	2.53e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—lung cancer	1.56e-05	2.51e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—lung cancer	1.54e-05	2.49e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HRAS—lung cancer	1.52e-05	2.46e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—lung cancer	1.51e-05	2.45e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KRAS—lung cancer	1.47e-05	2.37e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—lung cancer	1.46e-05	2.35e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CA—lung cancer	1.45e-05	2.34e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HRAS—lung cancer	1.45e-05	2.34e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—lung cancer	1.4e-05	2.26e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—lung cancer	1.39e-05	2.24e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CA—lung cancer	1.35e-05	2.18e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—lung cancer	1.34e-05	2.17e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HRAS—lung cancer	1.34e-05	2.16e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—lung cancer	1.31e-05	2.11e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—lung cancer	1.28e-05	2.07e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—lung cancer	1.28e-05	2.06e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HRAS—lung cancer	1.25e-05	2.02e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—lung cancer	1.2e-05	1.93e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—lung cancer	1.18e-05	1.91e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—lung cancer	1.1e-05	1.78e-05	CbGpPWpGaD
